Significance of apparent half-lives of a metabolite with a higher elimination rate than its parent drug.
D003975:Diazepam / Q000378:metabolism; D005965:Glucuronates / Q000378:metabolism; D006207:Half-Life; D006801:Humans; D007674:Kidney Diseases / Q000378:metabolism; D008657:Metabolic Clearance Rate; D010076:Oxazepam / Q000378:metabolism; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D013420:Sulfamethoxazole / Q000031:analogs & derivatives / Q000378:metabolism
D005965:Glucuronates; D004364:Pharmaceutical Preparations; C021282:N(4)-acetylsulfamethoxazole; D010076:Oxazepam; D013420:Sulfamethoxazole; D003975:Diazepam